Pa Juni 29, 2017, chitukuko cha laifoukutai, kalasi inones inchime, chidziwitso cha mgwirizano ndi ukadaulo wamankhwala a Me., Ltd., wapita patsogolo kwambiri. Chilengezo cha mankhwalawa chidavomerezedwa ndi CFDA.

Ngymed ndi Guangzhou Link Socurits Testicnolognology Commognology Co., Ltd. adafika pa mgwirizano wa mgwirizano mu 2016 kuti mupangitse izi ku China. Mitunduyi yamaliza maphunziro a Poc Clastical mu EU ndipo idakwaniritsa chitetezo chabwino komanso chikhululukiro. Onse a FDA ndi EMA akuzindikira kuti mitundu iyi ikhoza kuyikidwa pamankhwala pa chithandizo cha i / ii, ndi cholinga chake chidzaperekedwa kwa mpumulo ndi chithandizo cha odwala matenda a credic.

Zilonda zamitundu (UC) ndi matenda osachiritsika, osachimwa omwe amapezeka mu rectum ndi colon. Malinga ndi ziwerengero, kuchuluka kwa UC ndi 1.2 mpaka 20,3 milandu / anthu 100,000 pachaka komanso kufalikira kwa UC ndi 7.6 mpaka 246.0 Forts pachaka. Zotsatira za UC ndizofala kwambiri mu achichepere achichepere. Msika wa UC uli ndi gawo lalikulu komanso kufunikira kwa mankhwala osokoneza bongo, ndipo adzapitilizabe kukula mtsogolo. Pakadali pano, mankhwala oyamba-a UC koyambirira amatengera mesalazine ndi mahomoni, ndipo mankhwala amtundu wachiwiri amaphatikizapo immunosuppresperentnti ndi ma antibolodies. Mesalazine ali ndi voliyumu yogulitsa 1 biliyoni ku China ndi US $ 2 biliyoni ku United States mu 2015. Lafusoutai ali ndi yankho labwino ku zizindikiro za UC. Ili ndi mwayi wabwino wamsika ndipo akuyembekezeka kukhala mankhwala oyamba a UC.